AlphaCentric Advisors »

Abivax SA F shares owned by AlphaCentric Advisors

Quarter-by-quarter ownership of Abivax SA F (ABVX) shares owned by AlphaCentric Advisors from 13F filings

Historical chart of AlphaCentric Advisors investment in Abivax SA F

Tip: Access up to 7 years of quarterly data

All positions including Abivax SA F held by AlphaCentric Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abivax SA F by AlphaCentric Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $381k 3.4k 111.35

More positions owned by AlphaCentric Advisors

Gilead Sciences (GILD)
Invesco Exchange Traded Fd T S&p500 Pur Val (RPV)
Ishares Tr Rus 1000 Val Etf (IWD)
Astrazeneca Ord (AZN)
Vertex Pharmaceuticals Incorporated (VRTX)
Euronet Worldwide (EEFT)
Invitation Homes (INVH)
Ionis Pharmaceuticals (IONS)
Insmed Com Par $.01 (INSM)
Incyte Corporation (INCY)
Roivant Sciences SHS (ROIV)
Argenx Se Sponsored Adr (ARGX)
Neurocrine Biosciences (NBIX)
AMREP Corporation (AXR)
Saul Centers (BFS)

View all positions for AlphaCentric Advisors

Top funds holding Abivax SA F

TCG Crossover Management
UBS Group
Darwin Global Management
Morgan Stanley
Vestal Point Capital
Susquehanna International
Caligan Partners
ADAR1 Capital Management
FMR
Citadel Advisors
Westfield Capital Management Company
Barclays
Helikon Investments
Henderson Group
Baker Bros. Advisors

View all funds holding Abivax SA F